Showing 1 - 20 results of 25 for search 'StephenM. Ansell', query time: 0.04s
Refine Results
-
1
Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors by Maansi Joshi, Stephen M. Ansell
Published 2020-01-01
Article -
2
Unraveling the role of cancer-associated fibroblasts in B cell lymphoma by Prithviraj Mukherjee, Stephen M. Ansell, Patrizia Mondello
Published 2024-11-01
Article -
3
-
4
Interleukin-15 Affects Patient Survival through Natural Killer Cell Recovery after Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphomas by Luis F. Porrata, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Stephen M. Ansell, William J. Hogan, Svetomir N. Markovic
Published 2010-01-01
Article -
5
Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas by Luis F. Porrata, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo, Urshila Durani, Svetomir N. Markovic
Published 2024-08-01
Article -
6
Expression of KLRG1 and CD127 defines distinct CD8+ subsets that differentially impact patient outcome in follicular lymphoma by Hyo Jin Kim, Stephen M Ansell, Hongyan Wu, Anne J Novak, Xinyi Tang, Shahrzad Jalali, Joshua C Pritchett, Jose C Villasboas, Zhi-Zhang Yang
Published 2021-07-01
Article -
7
End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET by Karan L. Chohan, Jason R. Young, Scott Lester, Muhamad Alhaj Moustafa, Allison Rosenthal, Han W. Tun, Bradford S. Hoppe, Patrick B. Johnston, Ivana N. Micallef, Thomas M. Habermann, Stephen M. Ansell
Published 2022-12-01
Article -
8
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma by Ronald Levy, Joshua Brody, David L Porter, Sattva S Neelapu, Koen Van Besien, Michael Werner, Michael R Bishop, Mitchell S Cairo, Sherry Adkins, Stephen M Ansell, Jonathan W Friedberg, Justin P Kline
Published 2020-10-01
Article -
9
Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological maligna... by Andres E. Daryanani, Muhannad A. Abbasi, Maria F. Gomez Ardila, Eduardo Tellez-Garcia, Juan M. Garzon-Dangond, Yi Lin, Jonas Paludo, Joerg Herrmann, Stephen M. Ansell, Allison C. Rosenthal, Hector R. Villarraga
Published 2024-12-01
Article -
10
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma by Luis F. Porrata, Kay Ristow, Joseph P. Colgan, Thomas M. Habermann, Thomas E. Witzig, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Grzegorz S. Nowakowski, Carrie Thompson, Svetomir N. Markovic
Published 2012-02-01
Article -
11
Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity by Vaishali Bhardwaj, Zhi-Zhang Yang, Shahrzad Jalali, Jose C. Villasboas, Rekha Mudappathi, Junwen Wang, Prithviraj Mukherjee, Jonas Paludo, Xinyi Tang, Hyo Jin Kim, Jordan E. Krull, Kerstin Wenzl, Anne J. Novak, Patrizia Mondello, Stephen M. Ansell
Published 2024-12-01
Article -
12
Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy by Aung M. Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J. Inwards, Thomas M. Habermann, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Mohamed A Kharfan-Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston
Published 2024-01-01
Article -
13
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements by Ellen D. McPhail, Matthew J. Maurer, William R. Macon, Andrew L. Feldman, Paul J. Kurtin, Rhett P. Ketterling, Rakhee Vaidya, James R. Cerhan, Stephen M. Ansell, Luis F. Porrata, Grzegorz S. Nowakowski, Thomas E. Witzig, Thomas M. Habermann
Published 2018-11-01
Article -
14
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience by Steven R. Hwang, Richard C. Godby, Brianna J. Negaard, Raphael Mwangi, Adrienne N. Nedved, Jason N. Barreto, Ivana N. Micallef, Stephen M. Ansell, Luis Porrata, Urshila Durani, Gita Thanarajasingam, Thomas M. Habermann, Matthew J. Maurer, Patrick B. Johnston, Arushi Khurana
Published 2025-02-01
Article -
15
Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression by Sean I. Tracy, Thomas M. Habermann, Andrew L. Feldman, Matthew J. Maurer, Ahmet Dogan, Usha S. Perepu, Sergei Syrbu, Stephen M. Ansell, Carrie A. Thompson, George J. Weiner, Grzegorz S. Nowakowski, Cristine Allmer, Susan L. Slager, Thomas E. Witzig, James R. Cerhan, Brian K. Link
Published 2018-02-01
Article -
16
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study by Andrew M. Evens, Joseph M. Connors, Anas Younes, Stephen M. Ansell, Won Seog Kim, John Radford, Tatyana Feldman, Joseph Tuscano, Kerry J. Savage, Yasuhiro Oki, Andrew Grigg, Christopher Pocock, Monika Dlugosz-Danecka, Keenan Fenton, Andres Forero-Torres, Rachael Liu, Hina Jolin, Ashish Gautam, Andrea Gallamini
Published 2021-06-01
Article -
17
MicroRNA and long non-coding RNA analysis in IgM-monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis by Karan Chohan, Jonas Paludo, Surendra Dasari, Patrizia Mondello, Joseph P Novak, Jithma P. Abeykoon, Kerstin Wenzl, Zhi-Zhang Yang, Shahrzad Jalali, Jordan E Krull, Esteban Braggio, Michelle K. Manske, Aneel Paulus, Craig B. Reeder, Sikander Ailawadhi, Asher Chanan-Khan, Prashant Kapoor, Robert A. Kyle, Morie A Gertz, Anne J. Novak, Stephen M. Ansell
Published 2023-12-01
Article -
18
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma by Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish, Allison Rosenthal, Javier Munoz, Yi Lin, Radhika Bansal, Matthew A Hathcock, Patrick B Johnston, Stephen M Ansell, Jonas Paludo, Arushi Khurana, Jose C Villasboas, Yucai Wang, Madiha Iqbal, Muhamad Alhaj Moustafa, Hemant S Murthy, Mohamed A. Kharfan-Dabaja, Jennifer L Peterson, Bradford S Hoppe
Published 2023-06-01
Article -
19
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas by Melissa A. Hopper, Abigail R. Dropik, Janek S. Walker, Joseph P. Novak, Miranda S. Laverty, Michelle K. Manske, Xiaosheng Wu, Kerstin Wenzl, Jordan E. Krull, Vivekananda Sarangi, Matthew J. Maurer, Zhi-Zhang Yang, Miles D. Del Busso, Thomas M. Habermann, Brian K. Link, Lisa M. Rimsza, Thomas E. Witzig, Stephen M. Ansell, James R. Cerhan, Dragan Jevremovic, Anne J. Novak
Published 2024-10-01
Article -
20
The significance of gradient expression of chromosome region maintenance protein 1 (exportin1) in large cell lymphoma by Jithma P. Abeykoon, Paul J. Hampel, Rebecca L. King, Adam J. Wood, Melissa C Larson, Kevin E. Nowakowski, Saurabh S. Zanwar, Surendra Dasari, Gordon J. Ruan, Aishwarya Ravindran, Linda E. Wellik, Jonas Paludo, Brian K. Link, James R. Cerhan, Stephen M. Ansell, Grzegorz S. Nowakowski, Carrie A Thompson, Matthew J. Maurer, Kerstin Wenzl, Anne J. Novak, Xiaosheng Wu, Thomas M. Habermann, Thomas E. Witzig
Published 2021-03-01
Article